Literature DB >> 20134095

Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis.

Yumiko Imai1, Keiji Kuba, Takayo Ohto-Nakanishi, Josef M Penninger.   

Abstract

Angiotensin-converting enzyme 2 (ACE2), a first homolog of ACE, regulates the renin-angiotensin system by counterbalancing ACE activity. Accumulating evidence in recent years has demonstrated a physiological and pathological role of ACE2 in the cardiovascular, renal and respiratory systems. For instance, in the acute respiratory distress syndrome (ARDS), ACE, AngII, and AT1R promote the disease pathogenesis, whereas ACE2 and the AT2R protect from ARDS. Importantly, ACE2 has been identified as a key SARS-coronavirus receptor and plays a protective role in SARS pathogenesis. Furthermore, the recent explosion of research into the ACE2 homolog, collectrin, has revealed a new physiological function of ACE2 as an amino acid transporter, which explains the pathogenic role of gene mutations in Hartnup disorder. This review summarizes and discusses the recently unveiled roles for ACE2 in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20134095     DOI: 10.1253/circj.cj-10-0045

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  81 in total

1.  Impaired nutrient signaling and body weight control in a Na+ neutral amino acid cotransporter (Slc6a19)-deficient mouse.

Authors:  Angelika Bröer; Torsten Juelich; Jessica M Vanslambrouck; Nadine Tietze; Peter S Solomon; Jeff Holst; Charles G Bailey; John E J Rasko; Stefan Bröer
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  ACE2 activation confers endothelial protection and attenuates neointimal lesions in prevention of severe pulmonary arterial hypertension in rats.

Authors:  Gang Li; Yinglong Liu; Yaobin Zhu; Aijun Liu; Yulin Xu; Xiaofeng Li; Zhiqiang Li; Junwu Su; Lizhong Sun
Journal:  Lung       Date:  2013-05-08       Impact factor: 2.584

Review 3.  Angiotensin II and vascular injury.

Authors:  Augusto C Montezano; Aurelie Nguyen Dinh Cat; Francisco J Rios; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

4.  An immunotherapeutic method for COVID-19 patients: a soluble ACE2-Anti-CD16 VHH to block SARS-CoV-2 Spike protein.

Authors:  Abdolkarim Sheikhi; Mohammad Hojjat-Farsangi
Journal:  Hum Vaccin Immunother       Date:  2020-07-14       Impact factor: 3.452

5.  Investigation of galectin-3 function in the reproductive tract by identification of binding ligands in human seminal plasma.

Authors:  Matthew R Kovak; Sarika Saraswati; David J Schoen; Alan B Diekman
Journal:  Am J Reprod Immunol       Date:  2014-05-23       Impact factor: 3.886

Review 6.  ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

Authors:  Ping Xu; Srinivas Sriramula; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-22       Impact factor: 3.619

7.  The effect of fluvastatin on cardiac fibrosis and angiotensin-converting enzyme-2 expression in glucose-controlled diabetic rat hearts.

Authors:  Young Hee Shin; Jeong Jin Min; Jong-Hwan Lee; Eun-Hee Kim; Go Eun Kim; Myung Hee Kim; Jeong Jin Lee; Hyun Joo Ahn
Journal:  Heart Vessels       Date:  2016-12-24       Impact factor: 2.037

8.  Soluble angiotensin converting enzyme 2 levels in chronic heart failure is associated with decreased exercise capacity and increased oxidative stress-mediated endothelial dysfunction.

Authors:  Zhili Shao; Andres Schuster; Allen G Borowski; Akanksha Thakur; Lin Li; Wai Hong Wilson Tang
Journal:  Transl Res       Date:  2019-07-04       Impact factor: 7.012

Review 9.  Ocular tropism of respiratory viruses.

Authors:  Jessica A Belser; Paul A Rota; Terrence M Tumpey
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

Review 10.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.